BGB-8035 is an Orally Active BTK Inhibitor for B-cell Malignancies and Immunology Research
Bruton tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in carcinogenic signaling. Meanwhile, it plays a central role in the signal transduction of B cell antigen…